Cargando…

Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma

OBJECTIVE: The purpose of this study was to evaluate the clinical efficacy of continuous low-dose temozolomide (TMZ) chemotherapy for recurrent and TMZ-refractory glioblastoma multiforme (GBM) and to study the relationship between its efficacy and microvessel density within the tumor. METHODS: Thirt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Jong-Yun, Yang, Seung Ho, Lee, Youn Soo, Lee, Su Youn, Kim, Jeana, Hong, Yong Kil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Neurosurgical Society 2015
Materias:	Clinical Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688311/ https://www.ncbi.nlm.nih.gov/pubmed/26713142 http://dx.doi.org/10.3340/jkns.2015.58.5.426

Ejemplares similares

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
por: Kim, Se-Hyuk, et al.
Publicado: (2018)

Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)

High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In vivo Compared with Monotherapy
por: Lee, Jung Eun, et al.
Publicado: (2018)

Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy
por: BAK, DONG-HO, et al.
Publicado: (2016)

Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma
por: Jin, Bong Joon, et al.
Publicado: (2011)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

COVD-29. CONTINUATION OF TEMOZOLOMIDE CHEMOTHERAPY IN A GLIOBLASTOMA PATIENT AFTER RESOLUTION OF COVID-19 PNEUMONIA
por: Thakkar, Jigisha, et al.
Publicado: (2020)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
por: She, Lei, et al.
Publicado: (2021)

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Clinical significance of microvessel density in multiple myeloma patients.
por: Ahn, M. J., et al.
Publicado: (2001)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Tumor Recurrence in a Glioblastoma Patient after Discontinuation of Prolonged Temozolomide Treatment
por: Tseng, Wei-Lung, et al.
Publicado: (2017)

Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study
por: Greenspoon, Jeffrey Noah, et al.
Publicado: (2014)

Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
por: Gholamin, Sharareh, et al.
Publicado: (2019)

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
por: Kast, Richard E., et al.
Publicado: (2014)

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
por: Faustino, Alexandre Ciuffi, et al.
Publicado: (2020)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
por: Wang, Yong, et al.
Publicado: (2019)

Continuous representation of tumor microvessel density and detection of angiogenic hotspots in histological whole-slide images
por: Kather, Jakob Nikolas, et al.
Publicado: (2015)

Prognostic value of microvessel density in cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2018)

Prognostic role of microvessel density in patients with glioma
por: Fan, Chaofeng, et al.
Publicado: (2019)

Glioblastoma Multiforme: Probing Solutions to Systemic Toxicity towards High-Dose Chemotherapy and Inflammatory Influence in Resistance against Temozolomide
por: Nasir, Sadia, et al.
Publicado: (2023)

RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy
por: Gan, Jing, et al.
Publicado: (2016)

Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
por: Huang, Bin, et al.
Publicado: (2021)

Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma
por: Ahn, Stephen, et al.
Publicado: (2022)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules
por: Kim, Sue Youn, et al.
Publicado: (2011)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Automatic quantification of microvessel density in urinary bladder carcinoma
por: Wester, K, et al.
Publicado: (1999)

Independent prognostic importance of microvessel density in endometrial carcinoma.
por: Salvesen, H. B., et al.
Publicado: (1998)

Independent prognostic importance of microvessel density in endometrial carcinoma
Publicado: (1998)

Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_mi7d8djf7k40i04ia76llmef4d